Chile Says Sinovac Shot 67% Effective vs Symptomatic Covid Cases.

COVID-19; COVID-19 vaccines

Chile's health ministry's study followed 10.5 million people enrolled in the country's public health insurance system and included people that had received one dose, two doses and no doses. (Bloomberg) -- A Chilean study said Sinovac Biotech Ltd.'s vaccine was 67% effective in preventing symptomatic Covid-19 infections, the first such evidence from a mass vaccination program. [Extracted from the article]

Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)